Adhera Therapeutics (ATRX) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisChartSEC FilingsBuy This Stock Adhera Therapeutics Short Interest DataAdhera Therapeutics (ATRX) has a short interest of 100 shares. This marks a -95.00% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 6 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest2,000 sharesChange Vs. Previous Month-95.00%Dollar Volume Sold Short$1.22Short Interest Ratio0.0 Days to CoverLast Record DateMarch 15, 2024Outstanding Shares11,630,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume0 sharesAverage Trading Volume6 sharesToday's Volume Vs. Average0% Short Selling Adhera Therapeutics? Sign up to receive the latest short interest report for Adhera Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartATRX Short Interest Over TimeATRX Days to Cover Over TimeATRX Percentage of Float Shorted Over Time Adhera Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/2024100 shares $1.22 -95.0%N/A0 $0.01 2/29/20242,000 shares $33.60 -85.0%N/A0 $0.02 2/15/202413,300 shares $212.80 No ChangeN/A0 $0.02 1/15/202414,600 shares $271.56 +7,200.0%N/A0 $0.02 12/31/2023200 shares $6.00 No ChangeN/A0 $0.03 11/30/202311,800 shares $179.36 +81.5%N/A0 $0.02 11/15/20236,500 shares $71.50 -53.2%N/A0 $0.01 10/31/202313,900 shares $148.73 +286.1%N/A0.1 $0.01 10/15/20233,600 shares $50.40 -59.6%N/A0 $0.01 9/30/20238,900 shares $267.00 +270.8%N/A0.1 $0.03 Get the Latest News and Ratings for ATRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adhera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 9/15/20232,400 shares $53.28 No ChangeN/A0 $0.02 7/31/2023100 shares $4.00 No ChangeN/A0 $0.04 6/15/20231,600 shares $80.00 -74.6%N/A0 $0.05 5/31/20236,300 shares $693.00 +28.6%N/A0.2 $0.11 5/15/20234,900 shares $489.51 +25.6%N/A0.1 $0.10 4/30/20233,900 shares $1.17 thousand No ChangeN/A0.3 $0.30 4/15/20233,900 shares $2.34 thousand No ChangeN/A5.6 $0.60 3/31/20233,900 shares $2.27 thousand No ChangeN/A2 $0.58 3/15/20233,900 shares $2.50 thousand No ChangeN/A0.6 $0.64 2/28/20233,900 shares $2.54 thousand No ChangeN/A1.2 $0.65 2/15/20233,900 shares $2.78 thousand No ChangeN/A4.9 $0.71 1/31/20233,900 shares $3.71 thousand -4.9%N/A0.6 $0.95 1/15/20234,100 shares $3.28 thousand No ChangeN/A13.7 $0.80 12/30/20224,100 shares $3.36 thousand No ChangeN/A6.8 $0.82 12/15/20224,100 shares $3.49 thousand +5.1%N/A2.6 $0.85 11/30/20223,900 shares $2.50 thousand -9.3%N/A1.6 $0.64 11/15/20224,300 shares $4.30 thousand No ChangeN/A1.3 $1.00 7/31/20223,800 shares $266.76 -76.4%N/A0 $0.07 7/15/202216,100 shares $966.00 -21.5%N/A0.6 $0.06 6/30/202220,500 shares $1.23 thousand +169.7%N/A1.2 $0.06 6/15/20227,600 shares $456.00 No ChangeN/A0.3 $0.06 5/15/20223,200 shares $212.80 -59.5%N/A0.1 $0.07 4/30/20227,900 shares $513.50 -4.8%N/A0.1 $0.07 4/15/20228,300 shares $581.00 -58.5%N/A0.3 $0.07 3/31/202220,000 shares $1.38 thousand +1,233.3%N/A0.3 $0.07 3/15/20221,500 shares $119.85 -79.5%N/A0 $0.08 2/28/20227,300 shares $481.80 -45.5%N/A0.1 $0.07 2/15/202213,400 shares $1.09 thousand +1,388.9%N/A0.1 $0.08 1/31/2022900 shares $89.55 -18.2%N/A0 $0.10 1/15/20221,100 shares $108.90 -8.3%N/A0 $0.10Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow 12/31/20211,200 shares $88.80 No ChangeN/A0 $0.07 11/30/20212,000 shares $175.40 -4.8%N/A0 $0.09 11/15/20212,100 shares $357.00 -32.3%N/A0 $0.17 10/29/20213,100 shares $589.00 +342.9%N/A0 $0.19 10/15/2021700 shares $168.00 +40.0%N/A0 $0.24 9/30/2021500 shares $106.40 No ChangeN/A0 $0.21 8/31/202116,000 shares $1.89 thousand +119.2%N/A0.1 $0.12 8/13/20217,300 shares $803.00 No ChangeN/A0 $0.11 6/15/202112,500 shares $1.50 thousand No ChangeN/A0 $0.12 3/15/20211,000 shares $110.00 -96.0%N/A0 $0.11 2/26/202125,100 shares $2.76 thousand +25,000.0%N/A0.4 $0.11 2/12/2021100 shares $8.52 No ChangeN/A0 $0.09 1/29/2021100 shares $10.00 -50.0%N/A0 $0.10 1/15/20211,400 shares $70.00 No ChangeN/A0.4 $0.05 12/31/20202,700 shares $137.16 +92.9%N/A0 $0.05 12/15/20201,400 shares $84.00 No ChangeN/A0.4 $0.06 11/30/20201,400 shares $112.00 -30.0%N/A0 $0.08 11/15/20202,000 shares $110.00 No ChangeN/A0.1 $0.06 10/15/20203,000 shares $165.00 No ChangeN/A0.1 $0.06 9/15/202018,200 shares $764.40 +550.0%N/A0.3 $0.04 ATRX Short Interest - Frequently Asked Questions What is Adhera Therapeutics' current short interest? Short interest is the volume of Adhera Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 100 shares of ATRX short. Learn More on Adhera Therapeutics' current short interest. Is Adhera Therapeutics' short interest increasing or decreasing? Adhera Therapeutics saw a drop in short interest during the month of March. As of March 15th, there was short interest totaling 100 shares, a drop of 95.0% from the previous total of 2,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Adhera Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Adhera Therapeutics: eFFECTOR Therapeutics, Inc. (0.13%), OncoSec Medical Incorporated (0.00%), PaxMedica, Inc. (0.01%), Ampio Pharmaceuticals, Inc. (0.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors Company ($3.36 billion), Occidental Petroleum Corporation ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply Company ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Adhera Therapeutics stock? Short selling ATRX is an investing strategy that aims to generate trading profit from Adhera Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Adhera Therapeutics? A short squeeze for Adhera Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ATRX, which in turn drives the price of the stock up even further. How often is Adhera Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATRX, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies EFTR Short Squeeze ONCSQ Short Squeeze PXMD Short Squeeze FFNTF Short Squeeze AGNPF Short Squeeze ALST Short Squeeze ALVOW Short Squeeze ABMC Short Squeeze AOBI Short Squeeze AMPE Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ATRX) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adhera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adhera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.